A transatlantic biotech rushes toward the clinic with a twist on classic protein degraders

The protein degradation space has erupted in the last few years, with investors goggling at the idea of eliminating problematic proteins via the body’s natural garbage disposal system. Now another candidate is bound for the clinic — but instead of using PROTACs, this one relies on a busy group of...

Click to view original post